Table 1:
Clinical Features of Increasing Tandem Duplication Length Within Exon 1 of TNFRSF11A Encoding RANK
Clinical Syndrome | PEBD | ESH | FEO | PDB2Jpn | PDB2Chn | PDB2Mex |
---|---|---|---|---|---|---|
Signal Peptide Elongation | 12 | 15 | 18 | 27 | 27 | 27 |
Mutation | 90dup12 | 84dup15 | 84dup18 | 75dup27 | 78dup27 | 77dup27 |
Number of known kindreds/cases | 1/1 | 1/2 | 6/79 | 1/6 | 1/6 | 1/2 |
Deafness | Yes, congenital | Yes, childhood | Yes, variable timing | Mild in childhood to early 20s | Mild in teens to early 20s | Mild in adulthood |
Tooth loss in childhood | Yes | Yes | Yes | No | No | No |
Hand involvement | Yes | Yes | No | Yes | Yes | Yes |
Skull involvement | Yes | Yes | No | Yes | Yes | Yes |
Mandible/maxilla involvement | Yes | No | No | Yes | Yes | Yes |
Pelvic involvement | Yes | Yes | No | Yes | Yes | Yes |
Hypercalcemia | No | Yes | No | Yes* | Rare/Mild | Yes* |
during immobilization
PEBD: panostotic expansile bone disease; ESH: expansile skeletal hyperphosphatasia; FEO: familial expansile osteolysis; PDB2: early-onset Paget’s disease of bone